We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin d Levels and Coronary Catheterization

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00749541
First Posted: September 9, 2008
Last Update Posted: December 16, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Assaf-Harofeh Medical Center
  Purpose

decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.

decreased levels were also found to be connected to increased cardiovascular mortality.

we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.

we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.


Condition
Vitamin D Deficiency

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: 25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA
blood samples

Estimated Enrollment: 100
Study Start Date: November 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1normal catheter.
abnormal catheter.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients undergoing an elective coronary catheterization over the age of 18.
Criteria

Inclusion Criteria:age

  • >18 years,
  • no known ihd

Exclusion Criteria:

  • renal failure ,
  • medications including vitamin d, calcium ,phosphate
  • hyper or hypoparathyroidism,
  • abnormal calcium or phosphate values,
  • known pathological coronary catheterization.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00749541


Locations
Israel
Assaf Harofeh Mc
Zerifin, Israel
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Principal Investigator: renana shor, md assaf harofeh mc
  More Information

Responsible Party: dr. renana shor, assaf harofeh medical center internal medicine a
ClinicalTrials.gov Identifier: NCT00749541     History of Changes
Other Study ID Numbers: vitamin d
First Submitted: September 7, 2008
First Posted: September 9, 2008
Last Update Posted: December 16, 2010
Last Verified: September 2008

Keywords provided by Assaf-Harofeh Medical Center:
vitamin d coronary catheterization

Additional relevant MeSH terms:
Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders
Vitamins
Vitamin D
Ergocalciferols
Micronutrients
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents